Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
03/26/2014 | EP2709729A1 4-amino-5-fluoro-3- [6- (4 -methylpiperazin- 1 - yl) - 1h - benzimidazol - 2 - yl]- 1h - quinoli n-2-one for use in the treatment of adenoid cystic carcinoma |
03/26/2014 | EP2709663A2 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers |
03/26/2014 | EP2709650A2 Hepatocyte growth factor mimics as therapeutic agents |
03/26/2014 | EP2709649A2 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth |
03/26/2014 | EP2709629A1 Novel cancer therapies and methods |
03/26/2014 | EP2709626A1 Method for treatment of advanced solid tumors |
03/26/2014 | EP2709623A2 Medicaments and methods for treating cancer |
03/26/2014 | EP2709612A2 Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells |
03/26/2014 | EP2535358A9 Radioactive metal-labeled anti-cadherin antibody |
03/26/2014 | CN203493942U Composite graphene hydrogel medicine carrier |
03/26/2014 | CN1997388B Mucinous glycoprotein (MUC-1) vaccine |
03/26/2014 | CN103687945A Anti-B7-H3 antibody |
03/26/2014 | CN103687858A Amino-substituted imidazopyridazines as MKNK1 kinase inhibitors |
03/26/2014 | CN103687852A 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors |
03/26/2014 | CN103687623A Cytotoxic benzodiazepine derivatives |
03/26/2014 | CN103687621A Monoclonal antibody and antigens for diagnosing and treating lung disease and injury |
03/26/2014 | CN103687609A A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
03/26/2014 | CN103667431A Applications and human related drugs of CCCH-type zinc finger protein expression gene |
03/26/2014 | CN103667430A Application and relevant medicament of nucleotide octamer binding protein expression gene |
03/26/2014 | CN103667424A Usage of human EIF3H gene and related medicaments |
03/26/2014 | CN103667423A Use and related medicine of human IFITM3 gene |
03/26/2014 | CN103667422A Use and related medicament of human CUL4B gene |
03/26/2014 | CN103667408A Method for preparing intestine nutritive peptide by using wheat |
03/26/2014 | CN103667407A Polypeptide-zinc metal complex as well as preparation method and application thereof |
03/26/2014 | CN103667347A Adenovirus capable of expressing anti-cancer gene efficiently, regulated by miRNA and capable of specifically proliferating in glioma cells and application thereof |
03/26/2014 | CN103667345A Anti-oncogene magnetic composite nanoparticle and preparation method thereof |
03/26/2014 | CN103667304A Nucleic acids |
03/26/2014 | CN103667295A siRNA for FOXC1 gene expression inhibition, and application thereof |
03/26/2014 | CN103667292A MicroRNA molecule related to breast cancer docetaxel drug resistance and application thereof |
03/26/2014 | CN103667287A Free triphosphate group-containing GLS (Glutaminase) specific siRNA (Small interfering RNA) and preparation method and applications thereof |
03/26/2014 | CN103667192A Atypical chronic myeloid leukemia cell line and preparation method thereof |
03/26/2014 | CN103667189A CD8 cytotoxic T-lymphocyte for treating lung cancer and preparation method thereof |
03/26/2014 | CN103667097A Bacillus sp.N11-8 and active component thereof having antitumor action |
03/26/2014 | CN103665384A Novel cationic graft copolymer, and preparation method and application of multiple composite non-viral gene vector |
03/26/2014 | CN103665170A Peptide therapeutic conjugates and uses thereof |
03/26/2014 | CN103665169A Three-function peptide-modified gene carrier as well as preparation method and application thereof |
03/26/2014 | CN103665165A Bispecific antibody targeting human CD47-SIRP alpha signal passage and preparation method and application thereof |
03/26/2014 | CN103665133A Alpha-conotoxin peptide LvIA/LvD21, and pharmaceutical composition and use thereof |
03/26/2014 | CN103665130A Alpha-conotoxin peptide TxIC/Txd1 and medicinal composition and application thereof |
03/26/2014 | CN103665114A Peptide and preparation method and use thereof, and pharmaceutical composition and preparation method of pharmaceutical composition |
03/26/2014 | CN103665107A Novel compound combining functions of dissolving thrombus, scavenging free radicals and targeting thrombus, as well as preparation method and application thereof |
03/26/2014 | CN103665106A Antineoplastic polypeptide and preparation method and applications thereof |
03/26/2014 | CN103665103A Method for separating out prostatic cancer (PC)-3 anticancer peptide by utilizing thermal reactant of setipinna taty antibacterial peptide liquid and anticancer peptide obtained by using method |
03/26/2014 | CN103665089A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103665088A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103665086A Extraction process and application of bletilla striata cycloartane triterpenoid |
03/26/2014 | CN103665082A Hemsleya cucurbitane tetracyclic triterpenoid compound, pharmaceutical compositions containing same and application of compound and pharmaceutical composition |
03/26/2014 | CN103665058A Styrene-acrylic sucrose ester glycoside compounds of prunus tomentosa, and preparation method and application thereof |
03/26/2014 | CN103665046A Ruthenium complex as well as preparation method and application thereof |
03/26/2014 | CN103665027A Alizarin vanadium complex, and preparation method and application thereof |
03/26/2014 | CN103664997A Antitumor compound extracted from gamboge and preparation method and application thereof |
03/26/2014 | CN103664991A Thiophene [2, 3-d] pyrimidine derivative as well as preparation method and use thereof |
03/26/2014 | CN103664986A Antineoplastic compound extracted from gamboges, preparation method and application of antineoplastic compound |
03/26/2014 | CN103664984A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103664983A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103664982A Arteannuin analogs and preparation method thereof |
03/26/2014 | CN103664979A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103664977A 4-sydnone substituted phenyl epipodophyllotoxin derivative and preparation method and application thereof |
03/26/2014 | CN103664973A Spiro-oxindole compounds and their use as therapeutic agents |
03/26/2014 | CN103664972A Derivatives and salts of diamino dihydrotriazine, and preparation method, composition and application thereof |
03/26/2014 | CN103664970A Salt of dehydroxyl narciprimine derivate |
03/26/2014 | CN103664969A Narciprimine derivative salt |
03/26/2014 | CN103664968A Salts of lycoris radiata lactone derivatives |
03/26/2014 | CN103664938A Benzopyrimidine-containing SYK inhibitor |
03/26/2014 | CN103664932A Indole grafted thiazole hydrazone derivatives, preparation method thereof and inhibiting effect of indole grafted thiazole hydrazone derivatives for polymerization of cancer cell microtubulin |
03/26/2014 | CN103664929A Dasatinib polycrystalline form medicament and preparation method thereof |
03/26/2014 | CN103664928A N-[5-(1,2,4-triazol-1-yl)thiazol-2-yl]fatty acid amide and application thereof |
03/26/2014 | CN103664927A N-[5-(1,2,4-triazole-1-yl)thiazole-2-yl]aryl amide, preparation method, and applications thereof |
03/26/2014 | CN103664926A Synthesis of pyrazoline thiazole derivatives and application of derivatives in anticancer drugs |
03/26/2014 | CN103664925A Heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines |
03/26/2014 | CN103664919A Compound used for preparing chemotherapeutical medicines |
03/26/2014 | CN103664908A Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity |
03/26/2014 | CN103664904A Gamma-secretase inhibitor and use thereof |
03/26/2014 | CN103664903A Benzoazepine compounds and preparation method and application thereof |
03/26/2014 | CN103664899A Heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines |
03/26/2014 | CN103664897A Dihydropyrimidine compounds and application thereof in medicines |
03/26/2014 | CN103664895A Pyridazinone compounds, preparation method thereof, medicinal composition and application thereof |
03/26/2014 | CN103664893A Novel DPP-4 inhibitor, and preparation method and medicinal application thereof |
03/26/2014 | CN103664892A Crystal of quinoline derivative |
03/26/2014 | CN103664890A Crystal of quinoline derivative and preparation method of crystal |
03/26/2014 | CN103664884A Tyrosine kinase inhibitor for nitrogen hetero-aromatic ring and derivatives thereof |
03/26/2014 | CN103664878A Hetero-aromatic ring and derivative type tyrosine kinase inhibitor thereof |
03/26/2014 | CN103664876A Quinoline derivative and usage thereof |
03/26/2014 | CN103664872A Salt of pyrryl isoquinoline ketone derivative |
03/26/2014 | CN103664871A Isoquinoline derivative salt |
03/26/2014 | CN103664839A Application of Inula wissmanniana lactone A and derivatives in preparing antineoplastic drugs |
03/26/2014 | CN103664802A Quinazoline analogs as receptor tyrosine kinase inhibitors |
03/26/2014 | CN103664787A Alkyne heteraromatic ring compound and application thereof |
03/26/2014 | CN103664786A Synthesis method of dihydro-pyrazole sulfonamide derivatives of salicylaldehydes and application of dihydro-pyrazole sulfonamide derivatives to preparation of anticancer drugs |
03/26/2014 | CN103664785A Synthesis of novel dihydro-pyrazole sulfonamide derivative and application of novel dihydro-pyrazole sulfonamide derivative in anti-cancer drug |
03/26/2014 | CN103664782A Isocorydine derivative as well as preparation method and application thereof |
03/26/2014 | CN103664777A 2-undecyl-3-methyl-hydroxyl-quinoline compound as well as preparation method, pharmaceutical composition and use thereof |
03/26/2014 | CN103664751A Synthesis of benzsulfamide HDAC (Histone Deacetylase) inhibitor and application of benzsulfamide HDAC inhibitor in resisting tumor |
03/26/2014 | CN103664738A Crystalline polymorphic substance of carboxamide compound L-malate |
03/26/2014 | CN103664734A Heterocyclic hydroxamic acid compound as well as pharmaceutical composition and application thereof |
03/26/2014 | CN103664689A Chalcone oxime derivatives having inhibiting effect on cancer cell tubulin polymerization, and preparation method thereof |
03/26/2014 | CN103664559A Modhephane type sesquiterpene derivatives with significant cytotoxic activity as well as preparation method and usage thereof |
03/26/2014 | CN103656692A Nano targeted or ordinary anticancer medicament with radiotherapy function and preparation method thereof |
03/26/2014 | CN103656684A Attenuated salmonella typhimurium and application of genetically engineered bacterium of attenuated salmonella typhimurium to preparation of medicines for treating pancreatic cancer |
03/26/2014 | CN103656683A Application of pattern recognition receptors RIG-I in preparation of antitumor drug |